Anzahl der Publikationen: 5
2020
Al-Sawaf, O.; Robrecht, S.; Bahlo, J.; Fink, A. M.; Cramer, P.; Tresckow, J. von; Lange, E.; Kiehl, M.; Dreyling, M.; Ritgen, M.; Duerig, J.; Tausch, E.; Schneider, C.; Stilgenbauer, S.; Wendtner, C. M.; Fischer, K.; Goede, V.; Hallek, M. und Eichhorst, B.
(2020):
Richter transformation in chronic lymphocytic leukemia (CLL)-a pooled analysis of German CLL Study Group (GCLLSG) front line treatment trials.
In: Leukemia, Bd. 35, Nr. 1: S. 169-176
2017
Cramer, P.; Tresckow, J. von; Bahlo, J.; Robrecht, S.; Al Sawaf, O.; Langerbeins, P.; Engelke, A.; Fink, A.-M.; Fischer, K.; Seiler, T.; Fischer von Weikersthal, L.; Hebart, H.; Kreuzer, K.-A.; Ritgen, M.; Kneba, M.; Wendtner, C.-M.; Stilgenbauer, S.; Eichhorst, B. und Hallek, M.
(2017):
BENDAMUSTINE (B), followed by OBINUTUZUMAB (G, GA101) and VENETOCLAX (A, ABT-199) in patients with chronic lymphocytic leukemia (CLL): CLL2-BAG PHASE-II-TRIAL of the German CLL Study Group (GCLLSG).
In: Hämatologica, Bd. 102: S. 171-172
Cramer, P.; Tresckow, J. von; Bahlo, J.; Robrecht, S.; Al-Sawaf, O.; Langerbeins, P.; Engelke, A.; Fink, A.-M.; Fischer, K.; Tausch, E.; Seiler, T.; Fischer von Weikersthal, L.; Hebart, H.; Kreuzer, K.-A.; Ritgen, M.; Kneba, M.; Wendtner, C.-M.; Stilgenbauer, S.; Eichhorst, B. und Hallek, M.
(2017):
Bendamustine (B), followed by obinutuzumab (G) and venetoclax (A) in patients with chronic lymphocytic leukemia (CLL): CLL2-BAG trial of the German CLL Study Group (GCLLSG).
In: Oncology Research and Treatment, Bd. 40: S. 24
2016
Maurer, C.; Langerbeins, P.; Bahlo, J.; Cramer, P.; Fink, A. M.; Pflug, N.; Engelke, A.; Tresckow, J. von; Kovacs, G.; Stilgenbauer, S.; Wendtner, C.-M.; Müller, L.; Ritgen, M.; Seiler, T.; Fischer, K.; Hallek, M. und Eichhorst, B.
(2016):
Effect of first-line treatment on second primary malignancies and Richter's transformation in patients with CLL.
In: Leukemia, Bd. 30, Nr. 10: S. 2019-2025
2008
Böttcher, S.; Ritgen, M.; Buske, S.; Gesk, S.; Klapper, Wolfram; Hoster, Eva; Hiddemann, Wolfgang; Unterhalt, Michael; Dreyling, Martin; Siebert, R.; Kneba, M. und Pott, Christiane
(2008):
Minimal residual disease detection in mantle cell lymphoma: methods and significance of four-color flow cytometry compared to consensus IGH-polymerase chain reaction at initial staging and for follow-up examinations.
In: Haematologica, Bd. 93, Nr. 4: S. 551-559
Diese Liste wurde am
Sat Aug 10 18:31:30 2024 CEST
erstellt.